Antitumoral potential of Chartergellus-CP1 peptide from Chartergellus communis wasp venom in two different breast cancer cell lines (HR+ and triple-negative).

MLA

Soares, Susana, et al. “Antitumoral Potential of Chartergellus-CP1 Peptide from Chartergellus Communis Wasp Venom in Two Different Breast Cancer Cell Lines (HR+ and Triple-Negative).” Toxicon, vol. 216, Sept. 2022, pp. 148–56. EBSCOhost, https://doi.org/10.1016/j.toxicon.2022.07.004.

APA

Soares, S., Lopes, K. S., Mortari, M., Oliveira, H., & Bastos, V. (2022). Antitumoral potential of Chartergellus-CP1 peptide from Chartergellus communis wasp venom in two different breast cancer cell lines (HR+ and triple-negative). Toxicon, 216, 148–156. https://doi.org/10.1016/j.toxicon.2022.07.004

Chicago

Soares, Susana, Kamila Soares Lopes, Márcia Mortari, Helena Oliveira, and Verónica Bastos. 2022. “Antitumoral Potential of Chartergellus-CP1 Peptide from Chartergellus Communis Wasp Venom in Two Different Breast Cancer Cell Lines (HR+ and Triple-Negative).” Toxicon 216 (September): 148–56. doi:10.1016/j.toxicon.2022.07.004.